The National Health Institute has reported that 25 people have succumbed to chikungunya virus in Colombia, South America, in less than a year.
Since the illness was identified in Colombia in July 2014, more than 180,000 cases have been confirmed, 25 people have died, and another 17 deaths are still being investigated as possibly caused by the virus, according to the data from the institute.
Chikungunya
Chikungunya is a viral disease spread by mosquito bites; it causes fever, severe joint pain and rash on the body. Chikungunya occurs in Africa, Asia and the Indian sub continent.
Advertisement
Chikungunya is a viral disease spread by the bite of infected Aedes Aegypti mosquitoes. The rarely fatal, but nevertheless serious virus sparks high fevers and severe joint aches, as well as headaches, nausea and extreme fatigue.
It has spread across the Caribbean, to Central America, Mexico and South America. There is no vaccine or treatment.
Source: Medindia
Source: Medindia
Chikungunya Virus may Soon Spread to the US
The first locally acquired case of chikungunya in America was reported in the Caribbean. Since then, chikungunya has been identified in 44 countries or territories throughout the Americas.
Advertisement
 Fumigation of Streets, Homes to Combat Chikungunya Outbreak in AcapulcoThe state of Guerrero, where Acapulco is located, has reported more than half of the chikungunya cases found in Mexico this month prompting fumigation measures. | Advertisement
|
Chikungunya Mutation Places Several Continents at Risk of Epidemic: Study
Researchers of University of Texas Medical Branch at Galveston were able to predict further adaptations of the chikungunya virus that recently spread from Africa to several continents.
Advertisement
Recommended Reading
Latest Chikungunya News
Researchers evaluated whether systemic anticancer therapies and comorbidities were associated with COVID-19 mortality among adults with cancer and COVID-19.
A multi-country study led by IVI in partnership with BBIL, funded by the Coalition for Epidemic Preparedness Innovations (CEPI) with support from the Ind-CEPI mission of the Department of Biotechnology, India starts clinical trial on chikungunya vaccine.
Combination of zika virus and chikungunya virus is found to trigger stroke. Stroke following zika and chikungunya virus can be deadly and also result in death.
Healthy gut bacteria reduces the severity of mosquito-borne viral infections like chikungunya, by regulating inflammation and the body's response to infection. They help reduce the community spread of infection by disrupting the virus transmission from one person to another via mosquitoes.
Structure of chikungunya virus promises to accelerate efforts to design drugs and vaccines to prevent or treat arthritis caused by chikungunya or related viruses.